Injective Protocol (INJ) traded at $5.85 on September 11, 2026, posting a 24-hour decline of 2.65% even as the token retained substantial gains built up over a longer timeframe.
Over the past seven days, INJ advanced 20.52%, a notable surge that placed it among the stronger performers in the broader crypto market for the period. The 30-day picture was similarly constructive, with the token up 27.21% over that stretch.
Despite the short-term pullback, Injective Protocol carried a market capitalization of $0.6 billion, reflecting its standing as a mid-tier digital asset by that measure.
The daily dip suggests some consolidation following the recent run-up, though the longer-term figures indicate the token has seen sustained buying interest across both the weekly and monthly windows.
